CST 1.54% 33.0¢ castile resources ltd

report from afeb meeting

  1. 4,086 Posts.

    Cellestis have posted a brief report from the AFEB meeting on their website.

    AFEB Update

    The text of the report is:

    Update on QuantiFERON-TB
    Cellestis presents to the Armed Forces Epidemiology Board (18-02-03)
    On 18th February 2003, the Armed Forces Epidemiology Board ("AFEB") of the US military, a
    joint military and civilian expert advisory board, met and considered the use of QuantiFERON -
    TB in the US armed services. Dr. Jim Rothel from Cellestis and other speakers presented on
    the subject of TB testing as it applies to the US military. The logistical and medical advantages
    of QuantiFERON - TB were discussed, as were the benefits of applying the recent CDC
    guidelines for-TB use and subsequent TB treatment. The presentations broadly detailed how
    the use of-TB in accordance with the CDC guidelines should result in more accurate diagnosis
    of TB leading to lesser treatment for TB infection in the military.
    Cellestis believes the process was open and the issues clearly understood. Cellestis was
    pleased with all presentations, discussions and questions.
    AFEB will confirm its decision and report on its recommendations for the use of QuantiFERON
    TB in the US armed services in the next 6 to 9 weeks. At this time, Cellestis will report further

watchlist Created with Sketch. Add CST (ASX) to my watchlist
(20min delay)
Mkt cap ! $65.90M
Open High Low Value Volume
32.0¢ 33.0¢ 32.0¢ $179.0K 553.8K

Buyers (Bids)

No. Vol. Price($)
4 139312 32.0¢

Sellers (Offers)

Price($) Vol. No.
33.0¢ 84177 2
View Market Depth
Last trade - 15.52pm 25/09/2020 (20 minute delay) ?
0.005 ( 1.56 %)
Open High Low Volume
32.5¢ 33.0¢ 32.0¢ 88726
Last updated 14.57pm 25/09/2020 (live) ?
CST (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.